TY - JOUR
T1 - Comparison of neurocognitive outcomes after carotid endarterectomy and carotid artery stenting
AU - Kim, Jerry J.
AU - Schwartz, Samuel
AU - Wen, Johnny
AU - De Virgilio, Christian
AU - Lobue, Abeline
AU - Walot, Irwin
AU - Koopmann, Matthew
AU - Donayre, Carlos
AU - White, Rodney A.
N1 - Publisher Copyright:
© 2015 by the Southeastern Surgical Congress.
PY - 2015/10/1
Y1 - 2015/10/1
N2 - Cognitive and emotional outcomes after carotid endarterectomy (CEA) and carotid artery stenting with embolic protection device (CAS + EPD) are not clear. Patients were entered prospectively into a United States Food and Drug Administration.approved singlecenter physiciansponsored investigational device exemption between 2004 and 2010 and received either CEA or CAS + EPD. Patients underwent cognitive testing preprocedure and at 6, 12, and 60 months postprocedure. Cognitive domains assessed included attention, memory, executive, motor function, visual spatial functioning, language, and processing speed. Beck Depression and anxiety scales were also compared. There were a total of 38 patients that met conventional indications for carotid surgery (symptomatic with .50% stenosis or asymptomatic with .70% stenosis).12 patients underwent CEA, whereas 26 patients underwent CAS + EPD. Both CEA and CAS + EPD patients showed postprocedure improvement in memory and executive function. No differences were seen at followup in regards to emotional dysfunction (depression and anxiety), attention, visual spatial functioning, language, motor function, and processing speed. Only two patients underwent neuropsychiatric testing at 60 months.these CAS + EPD patients showed sustained improvement in memory, visual spatial, and executive functions. In conclusion, cognitive and emotional outcomes were similar between CEA and CAS + EPD patients.
AB - Cognitive and emotional outcomes after carotid endarterectomy (CEA) and carotid artery stenting with embolic protection device (CAS + EPD) are not clear. Patients were entered prospectively into a United States Food and Drug Administration.approved singlecenter physiciansponsored investigational device exemption between 2004 and 2010 and received either CEA or CAS + EPD. Patients underwent cognitive testing preprocedure and at 6, 12, and 60 months postprocedure. Cognitive domains assessed included attention, memory, executive, motor function, visual spatial functioning, language, and processing speed. Beck Depression and anxiety scales were also compared. There were a total of 38 patients that met conventional indications for carotid surgery (symptomatic with .50% stenosis or asymptomatic with .70% stenosis).12 patients underwent CEA, whereas 26 patients underwent CAS + EPD. Both CEA and CAS + EPD patients showed postprocedure improvement in memory and executive function. No differences were seen at followup in regards to emotional dysfunction (depression and anxiety), attention, visual spatial functioning, language, motor function, and processing speed. Only two patients underwent neuropsychiatric testing at 60 months.these CAS + EPD patients showed sustained improvement in memory, visual spatial, and executive functions. In conclusion, cognitive and emotional outcomes were similar between CEA and CAS + EPD patients.
UR - http://www.scopus.com/inward/record.url?scp=84944037184&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84944037184&partnerID=8YFLogxK
M3 - Article
C2 - 26463299
AN - SCOPUS:84944037184
SN - 0003-1348
VL - 81
SP - 1010
EP - 1014
JO - American Surgeon
JF - American Surgeon
IS - 10
ER -